Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice

Michele Petruzzelli, Elena Piccinin, Claudio Pinto, Claudia Peres, Elena Bellafante, Antonio Moschetta

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The proliferative-crypt compartment of the intestinal epithelium is enriched in phospholipids and accumulation of phospholipids has been described in colorectal tumors. Here we hypothesize that biliary phospholipid flow could directly contribute to the proliferative power of normal and dysplastic enterocytes. We used Abcb41-1 mice which lack biliary phospholipid secretion. We first show that Abcb41-1 mice are protected against intestinal tumorigenesis. At the molecular level, the transcriptional activity of the nuclear receptor Liver Receptor Homolog-1 (Lrh1) is reduced in Abcb41-1 mice and its re-activation re-establishes a tumor burden comparable to control mice. Feeding Abcb41-1 mice a diet supplemented with phospholipids completely overcomes the intestinal tumor protective phenotype, thus corroborating the hypothesis that the absence of biliary phospholipids and not lack of Abcb4 gene per se is responsible for the protection. In turn, phospholipids cannot re-establish intestinal tumorigenesis in Abcb41-1 mice crossed with mice with intestinal specific ablation of Lrh1, a nuclear hormone receptor that is activates by phospholipids. Our data identify the key role of biliary phospholipids in sustaining intestinal mucosa proliferation and tumor progression through the activation of nuclear receptor Lrh1.

Original languageEnglish (US)
Article number39278
JournalScientific Reports
Volume6
DOIs
StatePublished - Dec 20 2016

Fingerprint

Enterocytes
Cytoplasmic and Nuclear Receptors
Phospholipids
Neoplasms
Intestinal Mucosa
Liver
Carcinogenesis
Mouse Nr5a2 protein
Tumor Burden
Colorectal Neoplasms
Diet
Phenotype

ASJC Scopus subject areas

  • General

Cite this

Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice. / Petruzzelli, Michele; Piccinin, Elena; Pinto, Claudio; Peres, Claudia; Bellafante, Elena; Moschetta, Antonio.

In: Scientific Reports, Vol. 6, 39278, 20.12.2016.

Research output: Contribution to journalArticle

Petruzzelli, Michele ; Piccinin, Elena ; Pinto, Claudio ; Peres, Claudia ; Bellafante, Elena ; Moschetta, Antonio. / Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice. In: Scientific Reports. 2016 ; Vol. 6.
@article{35432103528942b09fff5a816e72059a,
title = "Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice",
abstract = "The proliferative-crypt compartment of the intestinal epithelium is enriched in phospholipids and accumulation of phospholipids has been described in colorectal tumors. Here we hypothesize that biliary phospholipid flow could directly contribute to the proliferative power of normal and dysplastic enterocytes. We used Abcb41-1 mice which lack biliary phospholipid secretion. We first show that Abcb41-1 mice are protected against intestinal tumorigenesis. At the molecular level, the transcriptional activity of the nuclear receptor Liver Receptor Homolog-1 (Lrh1) is reduced in Abcb41-1 mice and its re-activation re-establishes a tumor burden comparable to control mice. Feeding Abcb41-1 mice a diet supplemented with phospholipids completely overcomes the intestinal tumor protective phenotype, thus corroborating the hypothesis that the absence of biliary phospholipids and not lack of Abcb4 gene per se is responsible for the protection. In turn, phospholipids cannot re-establish intestinal tumorigenesis in Abcb41-1 mice crossed with mice with intestinal specific ablation of Lrh1, a nuclear hormone receptor that is activates by phospholipids. Our data identify the key role of biliary phospholipids in sustaining intestinal mucosa proliferation and tumor progression through the activation of nuclear receptor Lrh1.",
author = "Michele Petruzzelli and Elena Piccinin and Claudio Pinto and Claudia Peres and Elena Bellafante and Antonio Moschetta",
year = "2016",
month = "12",
day = "20",
doi = "10.1038/srep39278",
language = "English (US)",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice

AU - Petruzzelli, Michele

AU - Piccinin, Elena

AU - Pinto, Claudio

AU - Peres, Claudia

AU - Bellafante, Elena

AU - Moschetta, Antonio

PY - 2016/12/20

Y1 - 2016/12/20

N2 - The proliferative-crypt compartment of the intestinal epithelium is enriched in phospholipids and accumulation of phospholipids has been described in colorectal tumors. Here we hypothesize that biliary phospholipid flow could directly contribute to the proliferative power of normal and dysplastic enterocytes. We used Abcb41-1 mice which lack biliary phospholipid secretion. We first show that Abcb41-1 mice are protected against intestinal tumorigenesis. At the molecular level, the transcriptional activity of the nuclear receptor Liver Receptor Homolog-1 (Lrh1) is reduced in Abcb41-1 mice and its re-activation re-establishes a tumor burden comparable to control mice. Feeding Abcb41-1 mice a diet supplemented with phospholipids completely overcomes the intestinal tumor protective phenotype, thus corroborating the hypothesis that the absence of biliary phospholipids and not lack of Abcb4 gene per se is responsible for the protection. In turn, phospholipids cannot re-establish intestinal tumorigenesis in Abcb41-1 mice crossed with mice with intestinal specific ablation of Lrh1, a nuclear hormone receptor that is activates by phospholipids. Our data identify the key role of biliary phospholipids in sustaining intestinal mucosa proliferation and tumor progression through the activation of nuclear receptor Lrh1.

AB - The proliferative-crypt compartment of the intestinal epithelium is enriched in phospholipids and accumulation of phospholipids has been described in colorectal tumors. Here we hypothesize that biliary phospholipid flow could directly contribute to the proliferative power of normal and dysplastic enterocytes. We used Abcb41-1 mice which lack biliary phospholipid secretion. We first show that Abcb41-1 mice are protected against intestinal tumorigenesis. At the molecular level, the transcriptional activity of the nuclear receptor Liver Receptor Homolog-1 (Lrh1) is reduced in Abcb41-1 mice and its re-activation re-establishes a tumor burden comparable to control mice. Feeding Abcb41-1 mice a diet supplemented with phospholipids completely overcomes the intestinal tumor protective phenotype, thus corroborating the hypothesis that the absence of biliary phospholipids and not lack of Abcb4 gene per se is responsible for the protection. In turn, phospholipids cannot re-establish intestinal tumorigenesis in Abcb41-1 mice crossed with mice with intestinal specific ablation of Lrh1, a nuclear hormone receptor that is activates by phospholipids. Our data identify the key role of biliary phospholipids in sustaining intestinal mucosa proliferation and tumor progression through the activation of nuclear receptor Lrh1.

UR - http://www.scopus.com/inward/record.url?scp=85006819154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006819154&partnerID=8YFLogxK

U2 - 10.1038/srep39278

DO - 10.1038/srep39278

M3 - Article

C2 - 27995969

AN - SCOPUS:85006819154

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 39278

ER -